Patents-Review.com
ClassID:

117227 ⎘

C12Y305/02006 - CPC Classification

Classification description:

Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2) Beta-lactamase (3.5.2.6)

Recent Application in this class:
#1
20250297942
2025-09-25

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

 #2
20250075249
2025-03-06

AND-GATE ALLOSTERIC PROTEIN-BASED SWITCHES

 #3
20250059301
2025-02-20

Fusion Protein Construct

 #4
20240368575
2024-11-07

AN ENGINEERED YEAST CELL FOR THE DELIVERY OF ANTIBIOTIC-INACTIVATING ENZYMES

 #5
20240309369
2024-09-19

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

 #6
20240269247
2024-08-15

Microbiome protection from oral antibiotics

 #7
20240197842
2024-06-20

METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS

 #8
20240175801
2024-05-30

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

 #9
20240110220
2024-04-04

DETECTING BETA-LACTAMASE ENZYME ACTIVITY

 #10
20240082370
2024-03-14

SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION

 #11
20240024383
2024-01-25

ENGINEERED PROBIOTIC COMPOSITIONS AND USES THEREOF

 #12
20240011066
2024-01-11

PRODUCTION CELLS

 #13
20230416750
2023-12-28

CATALYTIC SEQUENCE BASED METHODS OF TREATING OR PREVENTING BACTERIAL INFECTIONS

 #14
20230405099
2023-12-21

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

 #15
20230398194
2023-12-14

METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE

 #16
20230366003
2023-11-16

TRANSGENIC BACTERIA WITH EXPANDED AMINO ACID USAGE AND NUCLEIC ACID MOLECULES FOR USE IN THE SAME

 #17
20230340036
2023-10-26

HETEROLOGOUS PROTEINS WITH AXONEMAL PROTEINS

 #18
20230332128
2023-10-19

MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO

 #19
20230313166
2023-10-05

BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY

 #20
20230280355
2023-09-07

METHODS FOR ASSAYING T-CELL DEPENDENT BISPECIFIC ANTIBODIES

 #21
20230279409
2023-09-07

-based production of beta-lactamase

 #22
20230270830
2023-08-31

Microbiome protection from oral antibiotics

 #23
20230265413
2023-08-24

COMPOSITIONS AND METHODS FOR ENZYME IMMOBILIZATION

 #24
20230190797
2023-06-22

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY

 #25
20220356487
2022-11-10

MAMMALIAN EXPRESSION VECTORS

 #26
20220356459
2022-11-10

BETA-LACTAMASE VARIANTS

 #27
20220251624
2022-08-11

Fluorescence-based reporters for mutagenesis detection in

#28
20220177947
2022-06-09

Compounds to Identify Beta-Lactamases, and Methods of Use Thereof

 #29
20220170934
2022-06-02

Assays for improving automated antimicrobial susceptibility testing accuracy

 #30
20220125895
2022-04-28

Safe and effective beta-lactamase dosing for microbiome protection

 #31
20220098566
2022-03-31

Beta-lactamases with improved properties for therapy

 #32
20220090044
2022-03-24

MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO

 #33
20210380645
2021-12-09

Efficient Protein Expression System for Expressing Bt Insecticidal Protein

 #34
20210332373
2021-10-28

-based production of beta-lactamase

 #35
20210318332
2021-10-14

Direct detection of the active form of beta-lactam-hydrolysing enzymes by using mass spectrophotometry

 #36
20210299170
2021-09-30

METHOD FOR IMPROVING ANTICANCER AGENT EFFICACY

 #37
20210220452
2021-07-22

Microbiome protection from oral antibiotics

 #38
20210054430
2021-02-25

Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same

 #39
20210010053
2021-01-14

ASSAYS FOR IMPROVING AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING ACCURACY

 #40
20210007994
2021-01-14

Beta-lactamase formulations and uses thereof

 #41
20200384092
2020-12-10

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

 #42
20200347375
2020-11-05

Beta-lactamases with improved properties for therapy

 #43
20200318094
2020-10-08

Beta-lactamase variants

 #44
20200297824
2020-09-24

Safe and effective beta-lactamase dosing for microbiome protection

 #45
20200268794
2020-08-27

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY

 #46
20200222514
2020-07-16

Carbapenemases for use with antibiotics for the protection of the intestinal microbiome

 #47
20200182882
2020-06-11

Methods for assaying T-cell dependent bispecific antibodies

 #48
20200157521
2020-05-21

Beta-lactamases with improved properties for therapy

 #49
20200123527
2020-04-23

Compositions and methods for enzyme immobilization

 #50
20200041413
2020-02-06

Portable wide field fluorimeter systems

 #51
20200017844
2020-01-16

Beta-lactamases with improved properties for therapy

 #52
20190330676
2019-10-31

Fluorescence-based reporters for mutagenesis detection in

#53
20190321453
2019-10-24

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

 #54
20190275120
2019-09-12

METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE

 #55
20190212339
2019-07-11

Assays for improving automated antimicrobial susceptibility testing accuracy

 #56
20190169590
2019-06-06

Modified beta-lactamases and methods and uses related thereto

 #57
20190161556
2019-05-30

Fusion protein construct

 #58
20190101538
2019-04-04

Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria

 #59
20190062719
2019-02-28

Beta-lactamase variants

 #60
20190048331
2019-02-14

Beta-lactamase variants

 #61
20180362954
2018-12-20

Beta-lactamases with improved properties for therapy

 #62
20180360762
2018-12-20

Beta-lactamase formulations and uses thereof

 #63
20180328923
2018-11-15

Synthetic hybrid receptor and genetic circuit in bacteria to detect enteric pathogenic microorganisms

 #64
20180311324
2018-11-01

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

 #65
20180305678
2018-10-25

Beta-lactamases with improved properties for therapy

 #66
20180221461
2018-08-09

Carbapenemases for use with antibiotics for the protection of the intestinal microbiome

 #67
20180136197
2018-05-17

CELL-FREE METHODS OF DETECTING BIOACTIVE LIGANDS

 #68
20180105862
2018-04-19

Methods for detecting beta-lactamase-producing bacteria

 #69
20180030458
2018-02-01

-based production of beta-lactamase

 #70
20180023072
2018-01-25

Beta-lactamases with improved properties for therapy

 #71
20170369433
2017-12-28

Beta lactamase inhibitors

 #72
20170368155
2017-12-28

Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics

 #73
20170350890
2017-12-07

Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria

 #74
20170327812
2017-11-16

Modified beta-lactamases and methods and uses related thereto

 #75
20170314006
2017-11-02

Beta-lactamases with improved properties for therapy

 #76
20170281737
2017-10-05

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

 #77
20170166945
2017-06-15

Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same

 #78
20170145402
2017-05-25

Modified beta-lactamases and methods and uses related thereto

 #79
20170073733
2017-03-16

CARBAPENEMASE AND ANTIBACTERIAL TREATMENT

 #80
20160362674
2016-12-15

Beta-lactamases with improved properties for therapy

 #81
20160326220
2016-11-10

SECRETION AND FUNCTIONAL DISPLAY OF CHIMERIC POLYPEPTIDES

 #82
20160303207
2016-10-20

Beta-lactamases with improved properties for therapy

 #83
20160256533
2016-09-08

Safe and effective beta-lactamase dosing for microbiome protection

 #84
20160250304
2016-09-01

CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME

 #85
20160230160
2016-08-11

Modified beta-lactamases and methods and uses related thereto

 #86
20160193307
2016-07-07

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

 #87
20160168557
2016-06-16

Modified beta-lactamases and methods and uses related thereto

 #88
20160101058
2016-04-14

Beta-lactamase formulations and uses thereof

 #89
20160031985
2016-02-04

CHARGE-ENGINEERED ANTIBODIES OR COMPOSITIONS OF PENETRATION-ENHANCED TARGETING PROTEINS AND METHODS OF USE

 #90
20160017341
2016-01-21

Universal protein overexpression tag comprising ramp function, and application thereof

 #91
20150297689
2015-10-22

Beta-lactamases with improved properties for therapy

 #92
20150209418
2015-07-30

Modified beta-lactamases and methods and uses related thereto

 #93
20150056178
2015-02-26

Modified beta-lactamases and methods and uses related thereto

 #94
20140273217
2014-09-18

Prodrug activation in cancer cells using molecular switches

 #95
20130216622
2013-08-22

Modified beta-lactamases and methods and uses related thereto

 #96
20130202616
2013-08-08

Compositions and methods for immunization against bacteria expressing a carbapenemase

 #97
20130045505
2013-02-21

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

 #98
20120185970
2012-07-19

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

 #99
20120122184
2012-05-17

Polypeptides of strain Bacillus sp. P203

 #100
20110135620
2011-06-09

Prodrug activation in cancer cells using molecular switches

 #101
20110135619
2011-06-09

Polypeptides of sp. having acid endoglucanase or acid cellulase activity

 #102
20110010805
2011-01-13

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

 #103
20110008800
2011-01-13

Method for Identifying an inhibitor of plasmidic classic C beta-lactamase having extended-substrate specifity

 #104
20100291543
2010-11-18

HOMOGENEOUS IN VITRO FEC ASSAYS AND COMPONENTS

 #105
20100222237
2010-09-02

Methods for generating polynucleotides having desired characteristics by iterative selection and recombination

 #106
20100196985
2010-08-05

Method and system for lactose-free or lactose-reduced milk and associated products, production thereof, and associated processes

 #107
20100151111
2010-06-17

Polypeptides of strain sp. P203

 #108
20090311234
2009-12-17

USE OF BETA-LACTAMASE

 #109
20090092707
2009-04-09

Polypeptides of sp. having glutamic peptidase activity

 #110
20090061421
2009-03-05

Crystal structure of CMY-10, a β-lactamase causing antibiotic resistance with extended-substrate spectrum

 #111
20080317666
2008-12-25

Colonic Delivery of Active Agents

 #112
20080261833
2008-10-23

METHODS FOR GENERATING POLYNUCLEOTIDES HAVING DESIRED CHARACTERISTICS BY ITERATIVE SELECTION AND RECOMBINATION

 #113
20080233100
2008-09-25

TARGETED ENZYMES

 #114
20080199528
2008-08-21

Colonic delivery of metallo-dependent enzymes

 #115
20080167194
2008-07-10

Protein Design Automation for Protein Libraries

 #116
20080119432
2008-05-22

Inhibition of metallo-β-lactamase by RNA

 #117
20080044400
2008-02-21

Targeted enzyme prodrug therapy

 #118
20070082381
2007-04-12

Polypeptides of Alicyclobacillus sp.

 #119
20060134086
2006-06-22

Targeted enzymes

 #120
20060030003
2006-02-09

Composition and method for introduction of RNA interference sequences into targeted cells and tissues

 #121
20050147983
2005-07-07

Polypeptides of Alicyclobacillus sp.

 #122
20050084868
2005-04-21

Generation of stabilized proteins by combinatorial consensus mutagenesis

 #123
15019474
2016-06-28

Beta-lactamases with improved properties for therapy